Centaurus Financial’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74K | Buy |
14,665
+3,555
| +32% | +$17.9K | ﹤0.01% | 954 |
|
|
2025
Q1 | $59K | Buy |
11,110
+336
| +3% | +$1.78K | ﹤0.01% | 886 |
|
|
2024
Q4 | $73K | Hold |
10,774
| – | – | ﹤0.01% | 859 |
|
|
2024
Q3 | $71K | Buy |
+10,774
| New | +$71K | ﹤0.01% | 832 |
|
|
2023
Q3 | – | Sell |
-13,242
| Closed | -$99K | – | 797 |
|
|
2023
Q2 | $99K | Buy |
13,242
+2,219
| +20% | +$16.6K | 0.01% | 734 |
|
|
2023
Q1 | $74K | Hold |
11,023
| – | – | 0.01% | 875 |
|
|
2022
Q4 | $85K | Buy |
11,023
+1,000
| +10% | +$7.71K | 0.01% | 810 |
|
|
2022
Q3 | $107K | Hold |
10,023
| – | – | 0.01% | 793 |
|
|
2022
Q2 | $82K | Buy |
+10,023
| New | +$82K | 0.01% | 810 |
|